Colorado 2026 Regular Session Status: Enacted Bipartisan · 17 D · 6 R cosponsors

HB 1336 — Increase Access to Pharmacy Services

Last action — Governor Signed

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 17, 2026. Enacted.

Signed by Governor Jared Polis (Democratic) on May 29, 2026.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 82% · high confidence
  • Enacted

    Current position in the legislative process.

  • 40 sponsors

    4 primary, 36 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (17 D · 6 R) — cross-party backing.

  • Mixed recorded votes

    7 passed, 2 failed in recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill expands pharmacists' ability to provide certain healthcare services and be reimbursed for them.

This legislation requires health benefit plans to reimburse pharmacists for services within their practice scope without collaborations and allows pharmacies to delegate verification tasks. It also expands pharmacists' prescriptive authority for specific conditions for younger patients.

What this means for you
  • Families: Families with children 5 years and older may benefit from easier access to minor treatment services from pharmacists.
  • Healthcare: Pharmacists will have more opportunities to provide and be reimbursed for services, improving patient care options.
  • Small Business: {}

Summary

If certain conditions are met, the act requires health benefit plans that provide hospital, surgical, or medical expense insurance to provide reimbursement for health-care services provided by a pharmacist that are within the pharmacist's scope of practice without entering into a collaborative pharmacy practice agreement. Similarly, under the medical assistance program (medicaid), the act authorizes reimbursement for services that are within a pharmacist's scope of practice and not duplicative of other pharmacist services or programs reimbursed by medicaid.     Further, solely on the basis of the type of license or certification, a health benefit plan or health insurance company (carrier) shall not discriminate against a pharmacist who is acting within the scope of the pharmacist's license or certification under state law, with respect to participation, referral, reimbursement of covered services, or indemnification, or prohibit a pharmacist from membership in a provider network; except that, in selecting pharmacist providers, the act does not:Prohibit a health benefit plan or carrier from including providers in its provider network only to the extent necessary to meet the needs of the plan or from limiting referrals or establishing quality control measures;Require a health benefit plan or carrier to contract with any provider willing to abide by the terms and conditions for participation established by the health benefit plan or carrier; orRequire coverage for any health-care service that is not otherwise covered.     The act makes changes to the definitions in the pharmacy practice statutes to include a definition for 'final product verification'. For drug, device, or product orders that are not for controlled substances, final product verification may be delegated by a supervising pharmacist to a certified pharmacy technician or pharmacy intern. A pharmacy or other outlet shall have a continuous quality assessment system in place to periodically verify the accuracy of the final drug, device, or product and must create a plan for final product verification, including how pharmacists' hours will be maintained to provide direct patient care. The state board of pharmacy is required to adopt rules relating to final product verification no later than December 31, 2026.     Under current law, a pharmacist may administer certain tests to patients who are 12 years old or older for certain conditions and prescribe drugs to treat the tested conditions. The act adds to the definition of the 'practice of pharmacy' independent prescriptive authority for drugs that are not controlled substances, drug categories, or devices that are prescribed to patients who are 5 years old or older but under 12 years old for conditions that do not require a new diagnosis, that are minor and self-limiting, or that have a test that guides diagnosis and are not medications that may only be prescribed pursuant to a certified education program and a limited distribution network. If a pharmacist tests or treats any patient who is under 18 years old, the act requires a pharmacist to notify the patient's primary care provider consistent with health-care privacy laws or, if the patient does not have or disclose a primary care provider, refer the patient to a primary care provider for further care.(Note: This summary applies to this bill as enacted.)

Bill Text

What changed in the latest version

205 added · 275 removed

Plain-language change summary

The recent amendments to House Bill 1336 include new language that clarifies that health benefit plans must provide coverage for healthcare services delivered by pharmacists under specific treatment protocols. This change removes previous wording that implied coverage was optional for certain health benefit plans. This matters because it emphasizes the importance of pharmacists in providing healthcare, ensuring that patients can access these services more reliably and potentially improving health outcomes.

→
Previous
Latest
Second Regular Session Seventy-fifth General Assembly STATE OF COLORADO REREVISED This Version Includes All Amendments Adopted in the Second House LLS NO.
NOTE:
26-0863.01 Brita Darling x2241 HOUSE BILL 26-1336 HOUSE SPONSORSHIP Lindsay and Winter T., Boesenecker, Brown, Clifford, Duran, Goldstein, Gonzalez R., Johnson, Marshall, McCluskie, McCormick, Nguyen, Rydin, Smith, Stewart K.
This bill has been prepared for the signatures of the appropriate legislative officers and the Governor.
SENATE SPONSORSHIP Pelton R.
To determine whether the Governor has signed the bill or taken other action on it, please consult the legislative status sheet, the legislative history, or the Session Laws.
and Cutter, Ball, Bright, Carson, Catlin, Coleman, Exum, Gonzales J., Jodeh, Kipp, Kolker, Marchman, Roberts, Snyder, Wallace, Weissman d d e m 2 T n 2 A U , E i y House Committees Senate Committees S a a Health & Human Services Health & Human Services e M d A BILL FOR AN ACT i a C ONCERNING MEASURES TO INCREASE ACCESS TO PHARMACY e 2 T d 20 N 2 5 SERVICES .
HOUSE BILL 26-1336 BYREPRESENTATIVE(S)LindsayandWinterT., Boesenecker,Brown, Clifford, Duran, Goldstein, Gonzalez R., Johnson, Marshall, McCormick, Nguyen, Rydin, Smith, Stewart K., McCluskie, Bacon, Barron, Caldwell, Mauro, Paschal, Rutinel, Soper;
E d y S d M e Bill Summary m A (Note:
also SENATOR(S) Pelton R.
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill d d passes third reading in the house of introduction, a bill summary that e 2 applies to the reengrossed version of this bill will be available at E a 0 S U , http://leg.colorado.gov.) O n 2 H a r e A Undercurrentlaw,apharmacistmayreceivereimbursementunder r ahealthbenefitplanandunderthemedicalassistanceprogram(medicaid) 3 for health-care services provided pursuant to a collaborative pharmacy practice agreement.
and Cutter, Ball, Bright, Carson, Catlin, Exum, Gonzales J., Jodeh, Kipp, Kolker, Marchman, Roberts, Snyder, Wallace, Weissman, Coleman.
If certain conditions are met, the bill requires health g benefitplansthatprovidehospital,surgical,ormedicalexpenseinsurance i 6 toprovidecoverageforhealth-careservicesprovidedbyapharmacistthat a 0 S R , U d 2 H 2 r Shading denotes HOUSE amendment.
CONCERNING MEASURES TO INCREASE ACCESS TO PHARMACY SERVICES .
Double underlining denotes SENATE amendment.
e Ap Capital letters or bold & italic numbers indicate new material to be added to existing law.n Dashes through the words or numbers indicate deletions from existing law.
e A are within the pharmacist's scope of practice.
Similarly, under medicaid, the bill authorizes reimbursement for services that are within a pharmacist's scope of practice and not duplicative of other pharmacist services or programs reimbursed by medicaid.
Further, solely on the basis of the type of license or certification, a health benefit plan or health insurance carrier shall not discriminate against a pharmacist who is acting within the scope of the pharmacist's license or certification under state law, with respect to participation, referral, reimbursement of covered services, or indemnification, or prohibit a pharmacist from membership in a provider's network.
Thebillmakeschangestothedefinitionsinthepharmacypractice statutes to include a definition for "final product verification", which is defined as a physical verification process for drug, device, or product orders filled through a pharmacy's electronic system after initial fill by a technicianorotherautomatedtechnology.Finalproductverificationmay be delegated by a supervising pharmacist to a certified pharmacy technician or pharmacyintern.
The process requires a pharmacyor other outlet to have a continuous quality assessment system in place to periodically verify the accuracy of the final drug, device, or product.
A pharmacy intending to implement a final product verification program shall create a plan for final product verification, including how pharmacists' hours will be maintained to provide direct patient care.
The stateboardofpharmacyisrequiredtoadoptrulesrelatingtofinalproduct verification.
Under current law, a pharmacist has independent prescriptive authorityfor drugs that are not controlled substances, drug categories, or devices that are prescribed to patients who are at least 12 years old, if certain conditions are met.
The bill also adds to the definition of the "practice of pharmacy" to include independent prescriptive authorityfor drugs that are not controlled substances, drug categories, or devices that areprescribedtopatientsyoungerthan12yearsoldforconditionsthatdo notrequireanewdiagnosis,that are minor and self-limiting, or that have a test that guides diagnosis and are not medications that may only be prescribed pursuant to a certified education program and a limited distribution network.
SECTION 1.
SECTION1.
In Colorado Revised Statutes, 10-16-144, amend (1) introductory portion, (1)(a), and (2) as follows:
InColoradoRevised Statutes,10-16-144,amend(1) introductory portion, (1)(a), and (2) as follows:
(1) Any A health benefit plan, except supplemental policies -2- 1336 covering a specified disease or other limited benefit, that provides hospital, surgical, or medical expense insurance mayST provide coverage for health-care services under a specific treatment protocol provided by a pharmacist if:
(1) Any A health benefit plan, except supplemental policies coveringaspecifieddiseaseorotherlimitedbenefit,thatprovideshospital, surgical, or medical expense insurance may MUST provide coverage for health-care services under a specific treatment protocol provided by a pharmacist if:
(a) Thepharmacist meets therequirementsinpart6of article280 of title 12 PROVIDING SERVICES THAT ARE WITHIN THE PHARMACIST S SCOPE OF PRACTICE UNDER ARTICLE 280OF TITLE12;
Capital letters or bold & italic numbers indicate new material added to existing law;
(2) (a) A health benefit plan described in subsection (1) of this section shall provide coverage for health-care services provided by a pharmacist within a health professional shortage area, as defined in 42 U.S.C.
dashes through words or numbers indicate deletions from existing law and such material is not part of the act.
sec.
(a) The pharmacist meets the requirements in part 6 of article 280 of title 1IS PROVIDING SERVICES THAT ARE WITHIN THE PHARMACIST S SCOPE OF PRACTICE UNDER ARTICLE 280 OF TITLE12;
254e, if the conditions specified in subsection (1) of this section are met.
(2) (a) A health benefit plan described in subsection (1) of this section shall provide coverage for health-care services provided by a pharmacist within a health professional shortage area, as defined in 42 U.S.C.sec.254e,iftheconditionsspecifiedinsubsection(1)ofthissection are met.
(b)(a) This subsection (2) does not require a carrier to contract withIF a pharmacy or pharmacistISwilling to abide by the terms and conditions for participation established by the health benefit plan or carrier,HEALTH BENEFIT PLAN OR CARRIER SHALL NOT DISCRIMINATE , WITH RESPECT TO PARTICIPATION ,REFERRAL , OR REIMBURSEMENT OF COVERED SERVICES OR INDEMNIFICATION AS TO PHARMACISTS WHO ARE ACTING WITHIN THE SCOPE OF THEIR LICENSE UNDER STATE LA,SOLELY ON THE BASIS OF THE TYPE OF LICENSURE.
(b)(a) Thissubsection(2)doesnotrequireacarriertocontractwith IFapharmacyorpharmacist ISwilling to abide bythe terms and conditions for participation established bythehealthbenefit plan or carrier, BENEFIT PLAN OR CARRIER SHALL NOT DISCRIMINATE ,WITH RESPECT TO PARTICIPATION ,REFERRAL ,OR REIMBURSEMENT OF COVERED SERVICES OR INDEMNIFICATIONASTOPHARMACISTSWHOAREACTINGWITHINTHESCOPE OFTHEIRLICENSE UNDERSTATELAW ,SOLELYONTHE BASIS OFTHE TYPE OF LICENSURE .
N SELECTING PROVIDERS OF HEALTH CARE SERVICES FOR MEMBERSHIP IN A PROVIDER NETWORK ,A HEALTH BENEFIT PLAN OR CARRIER SHALL NOT DISCRIMINATE AGAINST PHARMACISTS WHO PROVIDE SERVICES THAT ARE COVERED BY THE PLAN BY PROHIBITING PHARMACISTS FROM MEMBERSHIP IN A PROVIDER NETWORK .
N SELECTING PROVIDERS OF HEALTH -CARE SERVICES FOR MEMBERSHIPINAPROVIDERNETWORK ,AHEALTHBENEFITPLANORCARRIER SHALL NOT DISCRIMINATE AGAINST PHARMACISTS WHO PROVIDE SERVICES THAT ARE COVERED BY THE PLAN BY PROHIBITING PHARMACISTS FROM MEMBERSHIP IN A PROVIDER NETWORK .
(b) SBSECTION (2)(aOFTHISSECTIONSHALLNOTBECONSTRUED AS:
(b) SUBSECTION (2)(a)OF THIS SECTION SHALL NOT BE CONSTRUED AS:
-3- 1336 (I) P ROHIBITING A HEALTH BENEFIT PLAN OR CARRIER FROM INCLUDING PROVIDERS IN A PROVIDER NETWORK ONLY TO THE EXTENT NECESSARY TO MEET THE NEEDS OF THE HEALTH BENEFIT PLAN AND ITS ENROLLEES OR FROM LIMITING REFERRALS OR ESTABLISHING ANY OTHER MEASURE DESIGNED TO MAINTAIN QUALITY AND CONTROL COSTS CONSISTENT WITH THE PROVISIONS OF THE HEALTH BENEFIT PLA;
(I) PROHIBITING A HEALTH BENEFIT PLAN OR CARRIER FROM INCLUDING PROVIDERS IN A PROVIDER NETWORK ONLY TO THE EXTENT NECESSARY TO MEET THE NEEDS OF THE HEALTH BENEFIT PLAN AND ITS ENROLLEES OR FROM LIMITING REFERRALS OR ESTABLISHING ANY OTHER MEASURE DESIGNED TO MAINTAIN QUALITY AND CONTROL COSTS CONSISTENT WITH THE PROVISIONS OF THE HEALTH BENEFIT PLAN ;
(II) EQUIRINGAHEALTHBENEFITPLANORCARRIERTOCONTRACT WITH ANY PROVIDER WILLING TO ABIDE BY THE TERMS AND CONDITIONS FOR PARTICIPATION ESTABLISHED BY THE HEALTH BENEFIT PLAN OR CARRIER ;OR (III) R EQUIRING COVERAGE FOR ANY SERVICE THAT IS NOT OTHERWISE COVERED UNDER THE TERMS OF A HEALTH BENEFIT PLAN .
(II) REQUIRING A HEALTH BENEFIT PLAN OR CARRIER TO CONTRACT WITHANYPROVIDERWILLINGTOABIDEBYTHETERMSANDCONDITIONSFOR PARTICIPATIONESTABLISHEDBYTHEHEALTHBENEFITPLANORCARRIER ;OR (III) REQUIRING COVERAGE FOR ANY SERVICE THAT IS NOT OTHERWISE COVERED UNDER THE TERMS OF A HEALTH BENEFIT PLAN .
SECTION2.
PAGE 2-HOUSE BILL 26-1336 SECTION 2.
In Colorado RevisedStatutes,12-280-103,amend (38.5)(a)(X), (38.5)(a)(XI), (39)(g)(IV) introductory portion, (39)(g)(IV)(C), and (39)(g)(V);
In Colorado Revised Statutes, 12-280-103, amend (38.5)(a)(X), (38.5)(a)(XI), (39)(g)(IV) introductory portion, (39)(g)(IV)(C), and (39)(g)(V);
and add (17.5), (38.5)(a)(XII), and (39)(g)(VI) as follows:
and add (17.5), (38.5)(a)(XII), and (39)(g)(VII) as follows:
(17.5) "FINAL PRODUCT VERIFICATION" MEANS , AFTER PRESCRIPTION OR ORDER INFORMATION IS ENTERED INTO A PHARMACY S ELECTRONIC SYSTEM AND REVIEWED BY A PHARMACIST FOR ACCURACY , THERAPEUTICAPPROPRIATENESS ,ANDOTHERASPECTSOFDRUGREGIMEN REVIEW ,APHYSICALVERIFICATIONTHATTHEDRUG DEVICE ,ORPRODUCT SELECTED FROM THE PHARMACY S INVENTORY IS THE CORRECT DRUG , DRUG STRENGTH ,DRUG FORMULATION ,DEVICE ,OR PRODUCT FOR THE PRESCRIPTION OR ORDER.
(17.5) "FNALPRODUCTVERIFICATION "MEANS ,AFTERPRESCRIPTION OR ORDER INFORMATION IS ENTERED INTO A PHARMACY 'S ELECTRONIC SYSTEM AND REVIEWED BY A PHARMACIST FOR ACCURACY ,THERAPEUTIC APPROPRIATENESS , AND OTHER ASPECTS OF DRUG REGIMEN REVIEW ,A PHYSICAL VERIFICATION THAT THE DRUG ,DEVICE ,OR PRODUCT SELECTED FROMTHEPHARMACY 'SINVENTORYISTHECORRECTDRUG ,DRUGSTRENGTH , DRUG FORMULATION , DEVICE ,OR PRODUCT FOR THE PRESCRIPTION OR ORDER .
-4- 1336 (38.5)(a) "Practice as apharmacytechnician"meansengagingin anyofthefollowingactivitiesinvolvedinthepracticeofpharmacy,under the supervision and delegation of a supervising pharmacist:
(38.5) (a) "Practice as a pharmacy technician" means engaging in any of the following activities involved in the practice of pharmacy, under the supervision and delegation of a supervising pharmacist:
(X) Redispensing a prescription drug pursuant to section 12-280-141 (9)(b) and (9)(c);
(X) Redispensingaprescriptiondrugpursuanttosection12-280-141 (9)(b) and (9)(c);
and (XI) Requesting refill authorization from the prescriber or prescriber'sagentand receiving clarifying prescription informationfrom the prescriber or prescriber's agent;
and (XI) Requesting refill authorization from the prescriber or prescriber'sagentandreceivingclarifyingprescriptioninformationfromthe prescriber or prescriber's agent;D (XII) F INAL PRODUCT VERIFICATION FOR A DRUG ,DEVICE , OR PRODUCT THAT IS NOT A CONTROLLED SUBSTANCE .
(XII) F INAL PRODUCT VERIFICATION FOR A DRUG ,DEVICE ,OR PRODUCT THAT IS NOT A CONTROLLED SUBSTANCE .
(IV) Fordrugsthatarenotcontrolledsubstances,drugcategories, or devices that are prescribed in accordance with the product's FDA-approved labeling and to patients who are at least twelve years of age OLD and that are limited to conditions that:
(IV) For drugs that are not controlled substances, drug categories, or devices that are prescribed in accordance with the product's FDA-approvedlabelingandtopatientswhoareat least twelveyearsof age PAGE 3-HOUSE BILL 26-1336 OLD and that are limited to conditions that:
(C) Have a test that is used to guide diagnosis or clinical decision-making and is waived under the federal "Clinical Laboratory Improvement Amendments of 1988", Pub.L.
(C) Have a test that is used to guide diagnosis or clinical decision-making and is waived under the federal "Clinical Laboratory ImprovementAmendmentsof1988",Pub.L.100-578,asamended,or AND , IF TESTING OR TREATMENT OCCURS,FOR A PATIENT TWELVE YEARS OLD OR OLDER BUT UNDER EIGHTEEN YEARS OLD ,THE PATIENT S PRIMARY CARE PROVIDER IS NOTIFIED AS SOON AS PRACTICABLE CONSISTENT WITH THE FEDERAL "HEALTH INSURANCE P ORTABILITYAND A CCOUNTABILITYA CTOF 1996",PUB .L.104-191,OR,IF THE PATIENT DOES NOT HAVE OR DISCLOSE A PRIMARYCAREPROVIDER THEPATIENT 'SPHARMACISTREFERSTHEPATIENT TO A PRIMARY CARE PROVIDER FOR FURTHER CARE;
Show all 68 changed rows (28 more)
Previous
Latest
100-578, asamended, or AND ,IF TESTING OR TREATMENT OCCURS,FOR A PATIENT TWELVE YEARS OLDOROLDERBUTUNDEREIGHTEENYEARSOLD ,THEPATIENT SPRIMARY CARE PROVIDER IS NOTIFIED AS SOON AS PRACTICABLE CONSISTENT WITH THE FEDERAL "H EALTH NSURANCE PORTABILITY AND ACCOUNTABILITY A CT OF1996", PUB.L.
(V) ForanyFDA-approvedproductindicatedforopioidusedisorder in accordance with federal law and regulations, including medications for opioid use disorder, if authorized pursuant to part 6 of this article 280;
104-191OR ,IF THE PATIENT DOES NOT HAVE OR DISCLOSEAPRIMARYCAREPROVIDER THEPATIENT SPHARMACISTREFERS THE PATIENT TO A PRIMARY CARE PROVIDER FOR FURTHER CARE;
(VII) FOR DRUGS THAT ARE NOT CONTROLLED SUBSTANCES ,DRUG CATEGORIES ,ORDEVICESTHATAREPRESCRIBEDINACCORDANCEWITHTHE PRODUCT S FDA- APPROVED LABELING AND TO PATIENTS WHO ARE FIVE YEARS OLD OR OLDER BUT UNDER TWELVE YEARS OLD AND THAT ARE LIMITED TO CONDITIONS THAT:
(V) For any FDA-approved product indicated for opioid use -5- 1336 disorder in accordance with federal law and regulations, including medications for opioid use disorder, if authorized pursuant to part 6 of this article 280;
(A) D O NOT REQUIRE A NEW DIAGNOSI;
(VI) FOR DRUGSTHAT ARE NOT CONTROLLEDSUBSTANCES DRUG CATEGORIES ,OR DEVICES THAT ARE PRESCRIBED IN ACCORDANCE WITH THE PRODUCT S FDA- APPROVED LABELING AND TO PATIENTS WHO ARE FIVEYEARSOLDOROLDERBUTUNDERTWELVEYEARSOLDANDTHATARE LIMITED TO CONDITIONS THA:
(B) A RE MINOR AND GENERALLY SELF-LIMITING;OR (C) H AVE A TEST THAT IS USED TO GUIDE DIAGNOSIS OR CLINICAL DECISION -MAKING FOR INFLUENZA , SARS-C O V-2, GROUP A STREPTOCOCCUS , OR RESPIRATORY SYNCYTIAL VIRUS THAT IS WAIVED UNDERTHEFEDERAL "C LINICAL ABORATORY MPROVEMENT A MENDMENTS OF 1988", UB .L.
(A) DO NOT REQUIRE A NEW DIAGNOSI;
100-578AS AMENDED ;
(B) ARE MINOR AND GENERALLY SELF-LIMITIN;OR (C) HAVE A TEST THAT IS USED TO GUIDE DIAGNOSIS OR CLINICAL DECISION MAKING FOR INFLUENZA, SARS-C OV-2, GROUP A STREPTOCOCCUS ,OR RESPIRATORY SYNCYTIAL VIRUS THAT IS WAIVED UNDER THE FEDERAL "C LINICAL L ABORATORY IMPROVEMENT A MENDMENTSOF 1988",PUB.L.100-578,ASAMENDED ;DONOTREQUIRE MEDICATIONS THAT ARE ONLY PRESCRIBED PURSUANT TO A CERTIFIED EDUCATION PROGRAM AND A LIMITED DISTRIBUTION NETWORK ;AND ,IF TESTINGORTREATMENTOCCURS THEPATIENT SPRIMARYCAREPROVIDER IS NOTIFIED AS SOON AS PRACTICABLE CONSISTENT WITH THE FEDERAL "H EALTHINSURANCE PORTABILITYAND A CCOUNTABILITYA CTOF 1996", PUB .L.
DO NOT REQUIRE MEDICATIONS THAT ARE ONLY PRESCRIBED PURSUANT TO A CERTIFIED EDUCATION PROGRAM AND A LIMITED DISTRIBUTION NETWORK ;AND ,IF TESTING OR TREATMENT OCCURS ,THE PATIENTS PRIMARY CARE PROVIDER IS NOTIFIED AS SOON AS PRACTICABLE CONSISTENT WITH THE FEDERAL "H EALTH INSURANCE PORTABILITY AND A CCOUNTABILITY ACT OF 1996", PUB.L.
104-191OR, IF THE PATIENT DOES NOT HAVE OR DISCLOSE A PRIMARY CARE PROVIDER ,THE PATIENT S PHARMACIST REFERS THE PATIENT TO A PRIMARY CARE PROVIDER FOR FURTHER CAR;
104-191,OR,IFTHEPATIENTDOESNOTHAVEORDISCLOSEAPRIMARYCARE PROVIDER ,THE PATIEN'S PHARMACIST REFERS THE PATIENT TO A PRIMARY CARE PROVIDER FOR FURTHER CARE ;
SECTION3.
PAGE 4-HOUSE BILL 26-1336 SECTION3.
InColoradoRevisedStatutes,12-280-122,add(5) as follows:
InColoradoRevisedStatutes,12-280-122,add(5)as follows:
Limited authority to delegate activities constitutingpracticeofpharmacy topharmacyinternsorpharmacy -6- 1336 technicians - supervision ratio - final product verification - rules - definition.
Limitedauthoritytodelegateactivitiesconstituting practice of pharmacy to pharmacy interns or pharmacy technicians - supervision ratio - final product verification - rules - definition.
(5) (a) A SUPERVISING PHARMACIST MAY DELEGATE ,AND A PHARMACY TECHNICIAN OR AN INTERN MAY PERFORM UNDER THE SUPERVISIONOFTHESUPERVISINGPHARMACIST ,TASKSASSOCIATEDWITH THE PHYSICAL PREPARATION AND PROCESSING OF DRUG , DEVICE,OR PRODUCT ORDERS THAT ARE NOT FOR CONTROLLED SUBSTANCES .
(5) (a) A SUPERVISING PHARMACIST MAY DELEGATE , AND A PHARMACY TECHNICIAN OR AN INTERN MAY PERFORM UNDER THE SUPERVISION OF THE SUPERVISING PHARMACIST,TASKS ASSOCIATED WITH THE PHYSICAL PREPARATION AND PROCESSING OF DRUG , DEVICE, OR PRODUCT ORDERS THAT ARE NOT FOR CONTROLLED SUBSTANCES .
(b) FINAL PRODUCT VERIFICATION TASKS THAT MAY BE DELEGATED BY THE SUPERVISING PHARMACIST INCLUDE:
(b) FINALPRODUCT VERIFICATIONTASKSTHAT MAYBE DELEGATED BY THE SUPERVISING PHARMACIST INCLUDE :
(I) VERIFICATION OF THE PRESCRIPTION OR DRUG,DEVICE,OR PRODUCT BY A SECOND PHARMACY TECHNICIAN OR INTERN CONCERNING THE WORK OF THE FIRST PHARMACY TECHNICIAN OR INTER;
(I) V ERIFICATION OF THE PRESCRIPTION OR DRUG ,DEVICE, OR PRODUCTBYASECONDPHARMACYTECHNICIANORINTERNCONCERNINGTHE WORK OF THE FIRST PHARMACY TECHNICIAN OR INTERN ;
(II) USE OF BARCODE OR OTHER TECHNOLOGY TO VERIFY EACH DRUG ,DEVICE,ORPRODUCTPRIORTOADMINISTRATIONTOANINDIVIDUAL BY A HEALTH-CARE PROVIDER;
(II) USE OF BARCODE OR OTHER TECHNOLOGY TO VERIFY EACH DRUG ,DEVICE,OR PRODUCT PRIOR TO ADMINISTRATION TO AN INDIVIDUAL BY A HEALTH-CARE PROVIDER ;
(III) VERIFICATION BY A SECOND PHARMACY TECHNICIAN OR INTERNCONCERNINGTHEWORKOFTHEFIRSTPHARMACYTECHNICIANOR INTERN IN THE REPACKAGING OF DRUGS FROM BULK TO UNIT DOS;OR (IV) OTHER ACTIVITIES AS AUTHORIZED BY THE BOARD BY RU.E (c) I DELEGATING FINAL PRODUCT VERIFICATION TASKS , A SUPERVISING PHARMACIST SHALL USE THE PHARMACIST S REASONABLE PROFESSIONAL JUDGMENT AND SHALL ENSURE THAT AUTHORIZED TASKS DONOTREQUIRETHEEXERCISEOFDISCRETIONORCLINICALJUDGMENTBY A PHARMACY TECHNICIAN .
(III) VRIFICATIONBYASECONDPHARMACYTECHNICIANORINTERN CONCERNINGTHEWORKOFTHEFIRSTPHARMACYTECHNICIANORINTERNIN THE REPACKAGING OF DRUGS FROM BULK TO UNIT DOSE ;OR (IV) OTHER ACTIVITIES AS AUTHORIZED BY THE BOARD BY RULE.
(d) A PHARMACY OR OTHER OUTLET SHALL HAVE A CONTINUOUS QUALITY ASSESSMENT SYSTEM IN PLACE TO PERIODICALLY VERIFY THE ACCURACY OF A FINAL DRUG ,DEVICE,OR PRODUCT ,WHICH INCLUDES A -7- 1336 PROCESS FOR THE RECORDING AND EVALUATION OF ERRORS THAT OCCUR AND POTENTIAL ERRORS ,EVEN IF THE ERRORS DO NOT REACH THE PATIENT.
(c) IN DELEGATING FINAL PRODUCT VERIFICATION TASKS , A SUPERVISING PHARMACIST SHALL USE THE PHARMACIST 'S REASONABLE PROFESSIONALJUDGMENTANDSHALLENSURETHATAUTHORIZEDTASKSDO NOT REQUIRE THE EXERCISE OF DISCRETION OR CLINICAL JUDGMENT BY A PHARMACY TECHNICIAN .
(e) A PHARMACY INTENDING TO IMPLEMENT A FINAL PRODUCT VERIFICATIONPROGRAMSHALLCREATEANDMAINTAINAPROGRAMPLAN , INCLUDING HOW PHARMACISTS 'HOURS WILL BE MAINTAINED AND REDIRECTED FOR PROVIDING DIRECT PATIENT CARE ACTIVITI.S (f)NOLATERTHAN D ECEMBER 31,2026,THEBOARDSHALLADOPT RULES CONCERNING FINAL PRODUCT VERIFICATION BY A PHARMACY TECHNICIANOR INTERNPURSUANTTOTHISSUBSECTION (5).THEBOARD S RULES MUST INCLUDE:
(d) A PHARMACY OR OTHER OUTLET SHALL HAVE A CONTINUOUS QUALITY ASSESSMENT SYSTEM IN PLACE TO PERIODICALLY VERIFY THE ACCURACY OF A FINAL DRUG ,DEVICE, OR PRODUCT ,WHICH INCLUDES A PROCESS FOR THE RECORDING AND EVALUATION OF ERRORS THAT OCCUR PAGE 5-HOUSE BILL 26-1336 AND POTENTIALERRORS ,EVEN IF THE ERRORS DO NOT REACH THE PATIENT .
(I) TRAINING REQUIREMENTS;
(e) A PHARMACY INTENDING TO IMPLEMENT A FINAL PRODUCT VERIFICATION PROGRAM SHALL CREATE AND MAINTAIN A PROGRAM PLAN , INCLUDING HOW PHARMACISTS ' HOURS WILL BE MAINTAINED AND REDIRECTED FOR PROVIDING DIRECT PATIENT CARE ACTIVITIES .
(f) NO LATER THAN DECEMBER 31,2026, THE BOARD SHALL ADOPT RULES CONCERNING FINAL PRODUCT VERIFICATION BY A PHARMACY TECHNICIAN OR INTERN PURSUANT TO THIS SUBSECTION (5).
HE BOARD S RULES MUST INCLUDE :
(I) TAINING REQUIREMENTS ;
(III) LABILITY ISSU;AND (IV) ANY OTHER RULES THE BOARD DEEMS APPROPRIATE .
(III) LABILITY ISSUES;AND (IV) ANY OTHER RULES THE BOARD DEEMS APPROPRIATE .
(2)(a) Apharmacistiseligibletoreceivereimbursementunderthe medical assistance program for medically necessary services authorized in part 6 ofHAT ARE WITHIN THE PHARMACIST S SCOPE OF PRACTICE PURSUANT TO article 280 of titAND1that are not duplicative of other pharmacistservicesorprogramsreimbursedunderthemedicalassistance program.
(2) (a) A pharmacist is eligible to receive reimbursement under the medical assistance program for medicallynecessaryservices authorized in part 6 of THAT ARE WITHIN THE PHARMACIST S SCOPE OF PRACTICE PURSUANT TO article 280 of titleAND that are not duplicative of other pharmacist services or programs reimbursed under the medical assistance program.
on the day following the expiration of the -8- 1336 ninety-dayperiodafterfinaladjournmentofthegeneralassembly(August 12, 2026, if adjournment sine die is on May 13, 2026);
on the day following the expiration of the ninety-dayperiod after final adjournment of the general assembly(August 12, 2026, if adjournment sine die is on May 13, 2026);
except that, if a referendum petition is filed pursuant to section 1 (3) of article V of the state constitution against this act or an item, section, or part of this act within such period, then the act, item, section, or part will not take effect unless approved by the people at the general election to be held in November 2026 and, in such case, will take effect on the date of the official declaration of the vote thereon by the governor.
except that, if a referendumpetitionisfiledpursuanttosection1(3)ofarticleVofthestate constitution against this act or an item, section, or part of this act within such period, then the act, item, section, or part will not take effect unless PAGE 6-HOUSE BILL 26-1336 approvedbythepeopleatthegeneralelectiontobeheldinNovember2026 and, in such case, will take effect on the date of the official declaration of the vote thereon by the governor.
-9- 1336
____________________________ ____________________________ Julie McCluskie James Rashad Coleman, Sr.
SPEAKER OF THE HOUSE PRESIDENT OF OF REPRESENTATIVES THE SENATE ____________________________ ____________________________ Vanessa Reilly Esther van Mourik CHIEF CLERK OF THE HOUSE SECRETARY OF OF REPRESENTATIVES THE SENATE APPROVED________________________________________ (Date and Time) _________________________________________ Jared S.
Polis GOVERNOR OF THE STATE OF COLORADO PAGE 7-HOUSE BILL 26-1336
View plain text versions (7)

Action History

  1. Governor Signed

  2. Signed by the Speaker of the House

  3. Signed by the President of the Senate

  4. Sent to the Governor

  5. House Considered Senate Amendments - Result was to Concur - Repass

  6. Senate Third Reading Passed - No Amendments

  7. Senate Second Reading Special Order - Passed with Amendments - Committee

  8. Senate Committee on Health & Human Services Refer Amended - Consent Calendar to Senate Committee of the Whole

  9. Introduced In Senate - Assigned to Health & Human Services

  10. House Third Reading Passed - No Amendments

  11. House Second Reading Special Order - Passed with Amendments - Committee, Floor

  12. House Second Reading Laid Over Daily - No Amendments

  13. House Committee on Health & Human Services Refer Amended to House Committee of the Whole

  14. Introduced In House - Assigned to Health & Human Services

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 36 co-sponsors · 61 not signed on · 13 voted No

Sponsors (4)

Co-sponsors (36)

Not signed on (61)

61 members have not signed on to this bill.

Show all 61 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

CONCUR

Passed 64 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 40001
Republican 19000
Unaffiliated 5000
Total 64001
% of votes cast 98%0%0%2%
How each member voted (65)
Member Party Vote
Gonzalez R. — Yea
Stewart K. — Yea
Stewart R. — Yea
Winter T. — Yea
Garcia Sander — Yea
Alex Valdez Democrat Yea
Amy Paschal Democrat Yea
Andrew Boesenecker Democrat Yea
Bob Marshall Democrat Yea
Brianna Titone Democrat Yea
Cecelia Espenoza Democrat Yea
Chad Clifford Democrat Yea
Eliza Hamrick Democrat Yea
Elizabeth Velasco Democrat Yea
Emily Sirota Democrat Yea
Gretchen Rydin Democrat Yea
Jacque Phillips Democrat Yea
Jamie Jackson Democrat Yea
Javier Mabrey Democrat Yea
Jennifer Bacon Democrat Yea
Jenny Willford Democrat Yea
Julie McCluskie Democrat Yea
Junie Joseph Democrat Yea
Karen McCormick Democrat Yea
Kenny Nguyen Democrat Yea
Kyle Brown Democrat Yea
Lesley Smith Democrat Yea
Lindsay Gilchrist Democrat Yea
Lisa Feret Democrat Not Voting
Lorena Garcia Democrat Yea
Lori Goldstein Democrat Yea
Mandy Lindsay Democrat Yea
Manny Rutinel Democrat Yea
Matthew Martinez Democrat Yea
Meg Froelich Democrat Yea
Meghan Lukens Democrat Yea
Michael Carter Democrat Yea
Monica Duran Democrat Yea
Naquetta Ricks Democrat Yea
Regina English Democrat Yea
Sean Camacho Democrat Yea
Sheila Lieder Democrat Yea
Steven Woodrow Democrat Yea
Tammy Story Democrat Yea
Tisha Mauro Democrat Yea
Yara Zokaie Democrat Yea
Anthony Hartsook Republican Yea
Ava Flanell Republican Yea
Brandi Bradley Republican Yea
Carlos Barron Republican Yea
Chris Richardson Republican Yea
Dan Woog Republican Yea
Dusty Johnson Republican Yea
Jarvis Caldwell Republican Yea
Ken DeGraaf Republican Yea
Larry Don Suckla Republican Yea
Mary Bradfield Republican Yea
Matt Soper Republican Yea
Max Brooks Republican Yea
Rebecca Keltie Republican Yea
Rick Taggart Republican Yea
Ron Weinberg Republican Yea
Scott Bottoms Republican Yea
Scott Slaugh Republican Yea
Stephanie Luck Republican Yea

Official roll call →

REPASS

Passed 57 Yea · 7 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 39101
Republican 13600
Unaffiliated 5000
Total 57701
% of votes cast 88%11%0%2%
How each member voted (65)
Member Party Vote
Gonzalez R. — Yea
Stewart K. — Yea
Stewart R. — Yea
Winter T. — Yea
Garcia Sander — Yea
Alex Valdez Democrat Yea
Amy Paschal Democrat Yea
Andrew Boesenecker Democrat Yea
Bob Marshall Democrat Yea
Brianna Titone Democrat Yea
Cecelia Espenoza Democrat Yea
Chad Clifford Democrat Yea
Eliza Hamrick Democrat Yea
Elizabeth Velasco Democrat Yea
Emily Sirota Democrat Yea
Gretchen Rydin Democrat Yea
Jacque Phillips Democrat Yea
Jamie Jackson Democrat Yea
Javier Mabrey Democrat Yea
Jennifer Bacon Democrat Yea
Jenny Willford Democrat Yea
Julie McCluskie Democrat Yea
Junie Joseph Democrat Yea
Karen McCormick Democrat Yea
Kenny Nguyen Democrat Yea
Kyle Brown Democrat Yea
Lesley Smith Democrat Yea
Lindsay Gilchrist Democrat Nay
Lisa Feret Democrat Not Voting
Lorena Garcia Democrat Yea
Lori Goldstein Democrat Yea
Mandy Lindsay Democrat Yea
Manny Rutinel Democrat Yea
Matthew Martinez Democrat Yea
Meg Froelich Democrat Yea
Meghan Lukens Democrat Yea
Michael Carter Democrat Yea
Monica Duran Democrat Yea
Naquetta Ricks Democrat Yea
Regina English Democrat Yea
Sean Camacho Democrat Yea
Sheila Lieder Democrat Yea
Steven Woodrow Democrat Yea
Tammy Story Democrat Yea
Tisha Mauro Democrat Yea
Yara Zokaie Democrat Yea
Anthony Hartsook Republican Yea
Ava Flanell Republican Yea
Brandi Bradley Republican Nay
Carlos Barron Republican Yea
Chris Richardson Republican Yea
Dan Woog Republican Yea
Dusty Johnson Republican Yea
Jarvis Caldwell Republican Yea
Ken DeGraaf Republican Nay
Larry Don Suckla Republican Yea
Mary Bradfield Republican Yea
Matt Soper Republican Yea
Max Brooks Republican Nay
Rebecca Keltie Republican Yea
Rick Taggart Republican Yea
Ron Weinberg Republican Nay
Scott Bottoms Republican Nay
Scott Slaugh Republican Yea
Stephanie Luck Republican Nay

Official roll call →

Passed 7 Yea · 0 Nay
Party YeaNayPresentNot Voting
Republican 2000
Democrat 5000
Total 7000
% of votes cast 100%0%0%0%
How each member voted (7)
Member Party Vote
Iman Jodeh Democrat Yea
Kyle Mullica Democrat Yea
Lindsey Daugherty Democrat Yea
Lisa Cutter Democrat Yea
Mike Weissman Democrat Yea
Lisa Frizell Republican Yea
Scott Bright Republican Yea

Official roll call →

BILL

Passed 54 Yea · 10 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 37301
Republican 12700
Unaffiliated 5000
Total 541001
% of votes cast 83%15%0%2%
How each member voted (65)
Member Party Vote
Gonzalez R. — Yea
Stewart K. — Yea
Stewart R. — Yea
Winter T. — Yea
Garcia Sander — Yea
Alex Valdez Democrat Not Voting
Amy Paschal Democrat Yea
Andrew Boesenecker Democrat Yea
Bob Marshall Democrat Yea
Brianna Titone Democrat Yea
Cecelia Espenoza Democrat Yea
Chad Clifford Democrat Yea
Eliza Hamrick Democrat Nay
Elizabeth Velasco Democrat Yea
Emily Sirota Democrat Yea
Gretchen Rydin Democrat Yea
Jacque Phillips Democrat Yea
Jamie Jackson Democrat Yea
Javier Mabrey Democrat Yea
Jennifer Bacon Democrat Yea
Jenny Willford Democrat Yea
Julie McCluskie Democrat Yea
Junie Joseph Democrat Yea
Karen McCormick Democrat Yea
Kenny Nguyen Democrat Yea
Kyle Brown Democrat Yea
Lesley Smith Democrat Yea
Lindsay Gilchrist Democrat Nay
Lisa Feret Democrat Yea
Lorena Garcia Democrat Yea
Lori Goldstein Democrat Yea
Mandy Lindsay Democrat Yea
Manny Rutinel Democrat Yea
Matthew Martinez Democrat Yea
Meg Froelich Democrat Yea
Meghan Lukens Democrat Yea
Michael Carter Democrat Yea
Monica Duran Democrat Yea
Naquetta Ricks Democrat Yea
Regina English Democrat Yea
Sean Camacho Democrat Yea
Sheila Lieder Democrat Nay
Steven Woodrow Democrat Yea
Tammy Story Democrat Yea
Tisha Mauro Democrat Yea
Yara Zokaie Democrat Yea
Anthony Hartsook Republican Yea
Ava Flanell Republican Yea
Brandi Bradley Republican Nay
Carlos Barron Republican Yea
Chris Richardson Republican Nay
Dan Woog Republican Yea
Dusty Johnson Republican Yea
Jarvis Caldwell Republican Yea
Ken DeGraaf Republican Nay
Larry Don Suckla Republican Yea
Mary Bradfield Republican Yea
Matt Soper Republican Yea
Max Brooks Republican Nay
Rebecca Keltie Republican Yea
Rick Taggart Republican Yea
Ron Weinberg Republican Nay
Scott Bottoms Republican Nay
Scott Slaugh Republican Yea
Stephanie Luck Republican Nay

Official roll call →

Failed 3 Yea · 10 Nay
Party YeaNayPresentNot Voting
Republican 0500
Democrat 3500
Total 31000
% of votes cast 23%77%0%0%
How each member voted (13)
Member Party Vote
Eliza Hamrick Democrat Nay
Gretchen Rydin Democrat Nay
Karen McCormick Democrat Nay
Katie Stewart Democrat Nay
Lindsay Gilchrist Democrat Yea
Lisa Feret Democrat Nay
Regina English Democrat Yea
Sheila Lieder Democrat Yea
Carlos Barron Republican Nay
Dan Woog Republican Nay
Dusty Johnson Republican Nay
Mary Bradfield Republican Nay
Ty Winter Republican Nay

Official roll call →

Passed 10 Yea · 3 Nay
Party YeaNayPresentNot Voting
Republican 5000
Democrat 5300
Total 10300
% of votes cast 77%23%0%0%
How each member voted (13)
Member Party Vote
Eliza Hamrick Democrat Nay
Gretchen Rydin Democrat Yea
Karen McCormick Democrat Yea
Katie Stewart Democrat Yea
Lindsay Gilchrist Democrat Nay
Lisa Feret Democrat Yea
Regina English Democrat Yea
Sheila Lieder Democrat Nay
Carlos Barron Republican Yea
Dan Woog Republican Yea
Dusty Johnson Republican Yea
Mary Bradfield Republican Yea
Ty Winter Republican Yea

Official roll call →

Passed 12 Yea · 1 Nay
Party YeaNayPresentNot Voting
Republican 5000
Democrat 7100
Total 12100
% of votes cast 92%8%0%0%
How each member voted (13)
Member Party Vote
Eliza Hamrick Democrat Yea
Gretchen Rydin Democrat Yea
Karen McCormick Democrat Yea
Katie Stewart Democrat Yea
Lindsay Gilchrist Democrat Yea
Lisa Feret Democrat Yea
Regina English Democrat Yea
Sheila Lieder Democrat Nay
Carlos Barron Republican Yea
Dan Woog Republican Yea
Dusty Johnson Republican Yea
Mary Bradfield Republican Yea
Ty Winter Republican Yea

Official roll call →

Failed 4 Yea · 9 Nay
Party YeaNayPresentNot Voting
Republican 0500
Democrat 4400
Total 4900
% of votes cast 31%69%0%0%
How each member voted (13)
Member Party Vote
Eliza Hamrick Democrat Yea
Gretchen Rydin Democrat Nay
Karen McCormick Democrat Nay
Katie Stewart Democrat Nay
Lindsay Gilchrist Democrat Yea
Lisa Feret Democrat Nay
Regina English Democrat Yea
Sheila Lieder Democrat Yea
Carlos Barron Republican Nay
Dan Woog Republican Nay
Dusty Johnson Republican Nay
Mary Bradfield Republican Nay
Ty Winter Republican Nay

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 1336 do?
If certain conditions are met, the act requires health benefit plans that provide hospital, surgical, or medical expense insurance to provide reimbursement for health-care services provided by a pharmacist that are within the pharmacist's scope of practice without entering into a collaborative pharmacy practice agreement. Similarly, under the medical assistance program (medicaid), the act authorizes reimbursement for services that are within a pharmacist's scope of practice and not duplicative of other pharmacist services or programs reimbursed by medicaid.     Further, solely on the basis of the type of license or certification, a health benefit plan or health insurance company (carrier) shall not discriminate against a pharmacist who is acting within the scope of the pharmacist's license or certification under state law, with respect to participation, referral, reimbursement of covered services, or indemnification, or prohibit a pharmacist from membership in a provider network; except that, in selecting pharmacist providers, the act does not:Prohibit a health benefit plan or carrier from including providers in its provider network only to the extent necessary to meet the needs of the plan or from limiting referrals or establishing quality control measures;Require a health benefit plan or carrier to contract with any provider willing to abide by the terms and conditions for participation established by the health benefit plan or carrier; orRequire coverage for any health-care service that is not otherwise covered.     The act makes changes to the definitions in the pharmacy practice statutes to include a definition for 'final product verification'. For drug, device, or product orders that are not for controlled substances, final product verification may be delegated by a supervising pharmacist to a certified pharmacy technician or pharmacy intern. A pharmacy or other outlet shall have a continuous quality assessment system in place to periodically verify the accuracy of the final drug, device, or product and must create a plan for final product verification, including how pharmacists' hours will be maintained to provide direct patient care. The state board of pharmacy is required to adopt rules relating to final product verification no later than December 31, 2026.     Under current law, a pharmacist may administer certain tests to patients who are 12 years old or older for certain conditions and prescribe drugs to treat the tested conditions. The act adds to the definition of the 'practice of pharmacy' independent prescriptive authority for drugs that are not controlled substances, drug categories, or devices that are prescribed to patients who are 5 years old or older but under 12 years old for conditions that do not require a new diagnosis, that are minor and self-limiting, or that have a test that guides diagnosis and are not medications that may only be prescribed pursuant to a certified education program and a limited distribution network. If a pharmacist tests or treats any patient who is under 18 years old, the act requires a pharmacist to notify the patient's primary care provider consistent with health-care privacy laws or, if the patient does not have or disclose a primary care provider, refer the patient to a primary care provider for further care.(Note: This summary applies to this bill as enacted.)
Who sponsors HB 1336?
HB 1336 is sponsored by M. Weissman, K. Wallace, M. Snyder, D. Roberts, J. Marchman, C. Kolker, C. Kipp, I. Jodeh, J. Gonzales, T. Exum, J. Coleman, M. Catlin, J. Carson, S. Bright, M. Ball, R. Pelton, L. Cutter, Mandy Lindsay (Democrat), Jennifer Bacon (Democrat), Carlos Barron (Republican), Andrew Boesenecker (Democrat), Kyle Brown (Democrat), Jarvis Caldwell (Republican), Lori Goldstein (Democrat), Ryan Gonzalez (Republican), Dusty Johnson (Republican), Bob Marshall (Democrat), Tisha Mauro (Democrat), Julie McCluskie (Democrat), Karen McCormick (Democrat), Kenny Nguyen (Democrat), Amy Paschal (Democrat), Manny Rutinel (Democrat), Lesley Smith (Democrat), Matt Soper (Republican), Katie Stewart (Democrat), Ty Winter (Republican), Monica Duran (Democrat), Chad Clifford (Democrat), and Gretchen Rydin (Democrat).
What is the current status of HB 1336?
This bill has been enacted into law. Introduced March 17, 2026. Enacted.
Where can I track HB 1336?
Track HB 1336 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1336

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 1336

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →